Literature DB >> 17426537

Preperitonal pelvic packing for hemodynamically unstable pelvic fractures: a paradigm shift.

C Clay Cothren1, Patrick M Osborn, Ernest E Moore, Steven J Morgan, Jeffrey L Johnson, Wade R Smith.   

Abstract

BACKGROUND: The current management of pelvic fracture patients who are hemodynamically unstable in the United States consists of aggressive resuscitation, mechanical stabilization, and angioembolization. Despite this multidisciplinary approach, our recent analysis confirms an alarming 40% mortality in these high-risk patients. Therefore, we pursued alternate therapies to improve patient outcomes. European trauma groups have suggested the technique of pelvic packing via laparotomy to directly address the venous bleeding that comprises 85% of pelvic fracture hemorrhage. We hypothesized that a modified technique of direct preperitoneal pelvic packing (PPP) would reduce the need for angiography, decrease blood transfusion requirements, and lower mortality.
METHODS: Since September 2004, all patients at our ACS-verified level I trauma center with hemodynamic instability and pelvic fractures underwent PPP/external fixation, according to our protocol. Statistics are reported as mean +/- SEM and analyzed using Student's t test.
RESULTS: During the study period, 28 consecutive patients underwent PPP. There was one protocol deviation of prePPP angiography to evaluate an extremity vascular injury. The majority were men (68%) with a mean age of 40 +/- 3.9 years and a mean injury severity score of 55 +/- 3.0. The mean emergency department (ED) systolic blood pressure was 77 +/- 3.0 mm Hg, heart rate was 120 +/- 4.3 bpm, and base deficit 13 +/- 0.8 mmol/L. Pelvic fracture classifications included lateral compression (LC) II (9), anteroposterior compression (APC) III (8), LC I (3), vertical shear (3), LC III (3), and APC II (2). Patients required 4 +/- 1.2 units of packed red blood cells (PRBCs) during 82 +/- 13 minutes in the ED. Blood transfusion requirements before postoperative surgical intensive care unit (SICU) admission compared with the subsequent 24 postoperative hours were significantly different (12 +/- 2.0 versus 6 +/- 1.1; p = 0.006). The first 4 patients underwent routine angiography postPPP, with 1 undergoing therapeutic embolization; 4 of the subsequent 24 patients underwent angioembolization with clinical concern of ongoing pelvic hemorrhage. Seven (25%) patients died from multiple organ failure (2), postinjury myocardial infarction/pulseless electrical activity (PEA) arrest (2), invasive mucormycosis (1), withdrawal of care (1), and closed head injury (1); there were no deaths as a result of acute blood loss.
CONCLUSIONS: PPP is a rapid method for controlling pelvic fracture-related hemorrhage that can supplant the need for emergent angiography. There is a significant reduction in blood product transfusion after PPP, and this approach appears to reduce mortality in this select high-risk group of patients.

Entities:  

Mesh:

Year:  2007        PMID: 17426537     DOI: 10.1097/TA.0b013e31803c7632

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  61 in total

1.  Multidisciplinary management of blunt pelvic trauma.

Authors:  Pavan Khanna; Ho Phan; Andrew Hal Hardy; Timothy Nolan; Paul Dong
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

2.  Initial experience using a pelvic emergency simulator to train reduction in blood loss.

Authors:  Tim Pohlemann; Ulf Culemann; Joerg H Holstein
Journal:  Clin Orthop Relat Res       Date:  2012-08       Impact factor: 4.176

3.  Levels of evidence in pelvic trauma: a bibliometric analysis of the top 50 cited papers.

Authors:  Ailbhe White-Gibson; Barry O'Neill; David Cooper; Michael Leonard; Brendan O'Daly
Journal:  Ir J Med Sci       Date:  2018-05-12       Impact factor: 1.568

Review 4.  Orthopaedic management in the polytrauma patient.

Authors:  Jason J Halvorson; Holly T-P Pilson; Eben A Carroll; Zhongyu John Li
Journal:  Front Med       Date:  2012-09-07       Impact factor: 4.592

5.  Preperitoneal pelvic packing reduces mortality in patients with life-threatening hemorrhage due to unstable pelvic fractures.

Authors:  Clay Cothren Burlew; Ernest E Moore; Philip F Stahel; Andrea E Geddes; Amy E Wagenaar; Fredric M Pieracci; Charles J Fox; Eric M Campion; Jeffrey L Johnson; Cyril Mauffrey
Journal:  J Trauma Acute Care Surg       Date:  2017-02       Impact factor: 3.313

6.  [Interruption of the diagnostic algorithm and immediate surgical intervention after major trauma--incidence and clinical relevance. Analysis of the Trauma Register of the German Society for Trauma Surgery].

Authors:  T Lögters; R Lefering; J Schneppendahl; I Alldinger; I Witte; J Windolf; S Flohé
Journal:  Unfallchirurg       Date:  2010-10       Impact factor: 1.000

7.  [Control of diffuse bleeding in unstable pelvic fractures with compression plate packing: presentation of the surgical technique].

Authors:  A Biewener; S Rammelt; J Heineck; R Grass; H Zwipp; J Pyrc
Journal:  Unfallchirurg       Date:  2011-06       Impact factor: 1.000

Review 8.  Fractures of the pelvis in children: a review of the literature.

Authors:  Axel Gänsslen; Nima Heidari; Annelie M Weinberg
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-10-19

9.  Timeliness in obtaining emergent percutaneous procedures in severely injured patients: how long is too long and should we create quality assurance guidelines?

Authors:  Andrew Smith; Jean-Francois Ouellet; Daniel Niven; Andrew W Kirkpatrick; Elijah Dixon; Scott D'Amours; Chad G Ball
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

10.  Acute management of hemodynamically unstable pelvic trauma patients: time for a change? Multicenter review of recent practice.

Authors:  Diederik O Verbeek; Diederik Verbeek; Michael Sugrue; Zsolt Balogh; Danny Cass; Ian Civil; Ian Harris; Thomas Kossmann; Steve Leibman; Valerie Malka; Anthony Pohl; Sudhakar Rao; Martin Richardson; Michael Schuetz; Caesar Ursic; Vanessa Wills
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.